‡a
Author's Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
‡a
Author's DPP-4 inhibition resembles exercise in preventing type 2 diabetes development by inhibiting hepatic protein kinase Cε expression in a mouse model of hyperinsulinemia
‡a
Author's The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
‡a
correctiontotheassociationbetweenphosphorylatedneurofilamentheavychainpnfhandsmallfiberneuropathysfninpatientswithimpairedglucosetolerance
‡A
Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
‡9
1
‡a
dpp4inhibitionresemblesexerciseinpreventingtype2diabetesdevelopmentbyinhibitinghepaticproteinkinasecεexpressioninamousemodelofhyperinsulinemia
‡A
DPP-4 inhibition resembles exercise in preventing type 2 diabetes development by inhibiting hepatic protein kinase Cε expression in a mouse model of hyperinsulinemia
‡9
1
‡a
associationbetweenphosphorylatedneurofilamentheavychainpnfhandsmallfiberneuropathysfninpatientswithimpairedglucosetolerance
‡A
The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
‡9
1